{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/086/SRR25866386/SRR25866386_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/087/SRR25866387/SRR25866387_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/087/SRR25866387/SRR25866387_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/086/SRR25866386/SRR25866386_1.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Fudan University Shanghai Cancer Centre"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA1011273"],"long_description":["Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinoma"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"","description":"Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinoma","dates":{"last_updated":"2023-09-02","first_public":"2023-09-02"},"accession":"PRJNA1011273","cross_references":{}}